Tag archive

Fact.MR

Atherosclerosis Drugs Market Scaling New Heights, with Hospital Pharmacies Contributing US$ 26 Bn by 2027, finds Fact.MR

in Pharmaceutical News
Atherosclerosis Drugs Market Scaling New Heights, with Hospital Pharmacies Contributing US$ 26 Bn by 2027, finds Fact.MR

Convenience and large inventory remain key points of attraction for consumers, which makes hospital pharmacies the primary distribution channel in the global atherosclerosis drugs market. However, growing dependence of individuals on retail pharmacies, on the back of easy accessibility, could negatively impact sales generation through hospital pharmacies. According to a recent study, retail pharmacies are projected to witness a CAGR of 2.9% during 2020-2027. Key Highlights of Atherosclerosis Drugs Market Study A shift from the development of branded drugs to generic…

Keep Reading

Benzodiazepine Drugs Market Set to Record US$ 2.6 Bn by 2026; the U.S. to Remain Attractive Market, finds Fact.MR

in Pharmaceutical News
Benzodiazepine Drugs Market Set to Record US$ 2.6 Bn by 2026; the U.S. to Remain Attractive Market, finds Fact.MR

The U.S. is expected to account for around one-third of the total share in the global benzodiazepine drugs market by 2026. Growing prevalence of anxiety in parallel with rising awareness regarding benzodiazepine drugs is reflecting on increasing opportunities for players in the U.S. market. As per a report by the Anxiety and Depression Association of America (ADAA), each year, over 40 Mn adults in the U.S. suffer from anxiety disorders. Presence of a large number of hospital and retail pharmacies further makes…

Keep Reading

Go to Top